Position in VNDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,503,095
+$3,384,722 QoQ
Shares Held
1,225,996
+105.7% QoQ
Ownership
2.03%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 172 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. VNDA ranks #79 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in VNDA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,503,095 | 1,225,996 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $4,118,373 | 596,002 | Shares | Other | 2026-05-15 | |
| 2025-09-30 | $2,900,421 | 581,247 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $2,226,518 | 471,720 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $207,009 | 45,100 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $387,032 | 80,800 | Shares | Other | 2025-02-13 | |
| 2024-06-30 | $138,447 | 24,504 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $273,910 | 66,645 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $791,237 | 187,497 | Shares | Other | 2024-02-14 | |
| 2022-06-30 | $139,716 | 12,818 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $188,469 | 16,664 | Shares | Other | 2022-05-16 | |
| 2021-06-30 ALXN | — | 131,070 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 ALXN | — | 356,266 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 ALXN | — | 166,469 | Shares | Sole | 2021-02-16 | |
| 2020-12-31 | $1,590,071 | 121,010 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 ALXN | — | 49,461 | Shares | Sole | 2020-11-16 | |
| 2020-09-30 | $2,655,089 | 274,854 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 ALXN | — | 317,284 | Shares | Sole | 2020-08-13 | |
| 2020-06-30 | $1,153,071 | 100,793 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 ALXN | — | 109,815 | Shares | Sole | 2020-05-15 | |
| 2020-03-31 | $6,707,685 | 647,460 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||